MedTrace Logo

Intrathecal Mg in Gynecologic Laparoscopic Surgeries.

NCT02671227 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-01-27

No results posted yet for this study

Summary

The investigators aim to investigate the differences between intrathecal Bupivacaine + Mg sulfate in spinal anesthesia versus Bupivacaine on surgeon satisfaction and postoperative pain in gynecologic laparoscopic surgeries.

Conditions

  • Gynecologic Laparoscopic Surgery

Interventions

DRUG

intrathecal Mg sulfate.

intrathecal Mg sulfate 50 mg.

DRUG

intrathecal bupivacaine 15 mg.

intrathecal bupivacaine 15 mg.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671227 on ClinicalTrials.gov